LINQ II Insertable Cardiac Monitor vs iCAC Device
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II Insertable Cardiac Monitor if you require long-term, continuous, and highly accurate monitoring for diagnosing intermittent or suspected cardiac arrhythmias. Its AI-powered algorithms and remote programming capabilities are ideal for managing patients over several years, including pediatric populations, who need ongoing heart rhythm assessment.
View LINQ II Insertable Cardiac Monitor →Choose iCAC Device if…
Choose Bunkerhill Health's iCAC Device if you aim to opportunistically identify and quantify coronary artery calcium (CAC) from routine, non-contrast chest CT scans already performed for other indications. This tool is best suited for enhancing early cardiovascular disease detection and risk stratification by leveraging existing imaging data without requiring additional patient procedures.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | iCAC Device |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
LINQ II Insertable Cardiac MonitorTool A, the LINQ II, offers a more direct and comprehensive patient-facing usability with its MyCareLink Heartu2122 mobile app and MyCareLink Relayu2122 home communicator for remote monitoring and data transmission. Its remote programming capability also enhances convenience for both patients and clinicians by potentially reducing the need for in-person clinic visits.
Clinical Value
TieBoth tools offer significant and distinct clinical value. LINQ II provides crucial long-term, continuous monitoring and accurate arrhythmia diagnosis, including for pediatric patients, with evidence of risk prediction for AFib. The iCAC Device enables opportunistic, early detection and quantification of coronary artery calcium from existing CT scans, which has been shown to improve statin prescription rates and potentially reduce cardiovascular risk. Both address critical, yet different, aspects of cardiovascular health.
Pricing & Value
iCAC DeviceWhile both tools have non-public, enterprise-negotiated pricing, Tool B, the iCAC Device, has a clear advantage due to its recently secured CMS reimbursement pathway. This establishes a national billing code and a defined payment rate for its AI-enabled cardiovascular analysis, which significantly de-risks adoption for healthcare systems and provides a tangible financial mechanism for value realization.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic, as a long-established global medical device leader founded in 1949, with over a million patients using its ICMs worldwide, demonstrates a higher level of proven enterprise scale and maturity. Its explicit HIPAA compliance in the JSON and extensive support infrastructure further solidify its enterprise readiness.
Innovation
iCAC DeviceWhile Tool A's remote programming and AI for an implantable device are innovative, Tool B's core innovation lies in its ability to opportunistically detect and quantify coronary artery calcium from *existing, routine* CT scans not originally ordered for cardiac assessment. This approach transforms incidental findings into actionable insights for early disease detection, significantly expanding the reach of preventative cardiovascular care without additional scans or radiation.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic, as a large and established medical device company, offers a more comprehensive and clearly documented support infrastructure. This includes dedicated clinician and patient manuals, patient education materials, and multiple direct contact channels for technical and patient services, indicating a robust system for ongoing support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | iCAC Device |
|---|---|---|
| Primary Function | Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Company | Medtronic | Bunkerhill Health |
| Mobile App Support | both (MyCareLink Heartu2122 mobile app for data transmission) | Not specified |
| Core AI Capability | AccuRhythmu2122 AI algorithms for enhanced accuracy, innovative PVC detection algorithm. | Utilizes deep-learning algorithms for analysis to estimate presence and quantity of coronary artery calcium (CAC). |
| Specialties | Cardiology | Cardiology, Radiology |
| Data Source / Monitoring Type | Long-term, continuous heart rhythm monitoring (up to 4.5 years) | Analyzes routine, non-contrast, non-gated chest CT scans |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and iCAC Device.